Valacyclovir to reduce transmission of genital herpes simplex virus infection.
Drew
W Lawrence
WL
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004198:Disease Susceptibility; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006561:Herpes Simplex / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008297:Male; D010919:Placebos; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D010919:Placebos; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir